ATGAM Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: Patient and Graft Survival, CD3 Subset, Infection, and Cost Analysis

By Kumar M.S.A.   Cahill K.   Kumar A.M.S.   Panigrahi D.   Seirka D.   Singleton R.   Al-Abdullah I.H.   Laskow D.A.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1351-1352

Elsevier

Access to resources Recommend Favorite

Predicting Factors for Long-Term Results of OKT3 Therapy in Steroid-Resistant Acute Rejection Following Cadaveric Renal Transplantation - Approaches to Graft Rejection

By Rostaing L.   Chabannier M.-H.   Modesto A.   Rouzaud A.   Cisterne J.-M.   Tkaczuk J.   Durand D.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1170-1172

Elsevier

Access to resources Recommend Favorite

No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients

By Bemelman F.J.   Yong S.   Parlevliet K.J.   Surachno S.   Schellekens P.T.A.   ten Berge R.J.M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3165-3167

Elsevier

Access to resources Recommend Favorite

Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results

By Samsel R.   Rowinski W.   Chmura A.   Wlodarczyk Z.   Wyzgal J.   Cieciura T.   Lagiewska B.   Pliszczynski J.   Korczak G.   Paczek L.   Walaszewski J.   Lao M.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2952-2954

Elsevier

Access to resources Recommend Favorite

Long-Term Outcome With the Use of OKT3 Induction Therapy in Heart Transplant Patients: A Single-Center Experience

By Adamson R.   Obispo E.   Dychter S.   Dembitsky W.   Moreno-Cabral R.   Jaski B.   Gordon J.   Hoagland P.   Moore K.   King J.   Andrews J.   Rich M.   Daily P.O.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1107-1109

Elsevier

Access to resources Recommend Favorite